share_log

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Maintains $5 Price Target

Benzinga ·  Aug 17, 2023 11:48

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment